PT - JOURNAL ARTICLE AU - Pérez-Tanoira, Ramón AU - Pérez-García, Felipe AU - Romanyk, Juan AU - Gómez-Herruz, Peña AU - Arroyo, Teresa AU - González, Rosa AU - García, Lourdes Lledó AU - Expósito, Cristina Verdú AU - Moreno, José Sanz AU - Gutiérrez, Isabel AU - Mathews, Abel Uribe AU - Ramos, Esther López AU - Garcia, Lara Maceda AU - Troncoso, Daniel AU - Cuadros-González, Juan TI - Prevalence and risk factors for mortality related to COVID-19 in a severely affected area of Madrid, Spain AID - 10.1101/2020.05.25.20112912 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.25.20112912 4099 - http://medrxiv.org/content/early/2020/05/26/2020.05.25.20112912.short 4100 - http://medrxiv.org/content/early/2020/05/26/2020.05.25.20112912.full AB - BACKGROUND The coronavius disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reached Spain by 31 January 2020, in April 2020, the Comunidad de Madrid suffered one of the world’s highest crude mortality rate ratios. This study aimed to detect risk factors for mortality in patients with COVID-19.METHODS Our cohort were all consecutive adult patients (≥18 years) with laboratory-confirmed COVID-19 at a secondary hospital in Madrid, March 3-16, 2020. Clinical and laboratory data came from electronic clinical records and were compared between survivors and non-survivors, with outcomes followed up until April 4. Univariable and multivariable logistic regression methods allowed us to explore risk factors associated with in-hospital death.FINDINGS The cohort comprised 562 patients with COVID-19. Clinical records were available for evaluation for 392 patients attended at the emergency department of our hospital, of whom 199 were discharged, 85 remained hospitalized and 108 died during hospitalization. Among 311 of the hospitalized patients, 34.7% died. Of the 392 patients with records, the median age was 71.5 years (50.6-80.7); 52.6% were men. 252 (64.3%) patients had a comorbidity, hypertension being the most common: 175 (44.6%), followed by other cardiovascular disease: 102 (26.0%) and diabetes: 97 (24.7%). Multivariable regression showed increasing odds of in-hospital death associated with age over 65 (odds ratio 8.32, 95% CI 3.01–22.96; p<0.001), coronary heart disease (2.76, 1.44-5.30; 0.002), and both lower lymphocyte count (0.34, 0.17–0.68; 0.002) and higher LDH (1.25, 1.05-1.50; 0.012) per 1-unit increase and per 100 units respectively.INTERPRETATION COVID-19 was associated in our hospital at the peak of the pandemic with a crude mortality ratio of 19.2% and a mortality ratio of 34.7% in admitted patients, considerably above most of the ratios described in the Chinese series. These results leave open the question as to which factors, epidemiological or intrinsically viral, apart from age and comorbidities, can explain this difference in excess mortality.FUNDING None.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was conducted according to the ethical requirements established by the Declaration of Helsinki. The Ethics Committee of Hospital Universitario Principe de Asturias (Madrid) approved the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data referred are availability from the corresponding author on reasonable request.